BFC Planning’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
TGY2IT
CM
BFC Planning's CHRS Position: Q3 2026 in Review
BFC Planning held its Coherus Oncology (CHRS) position steady in Q3 2026 at 5,000 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.
BFC Planning first reported a position in CHRS in Q3 2024 and has held it in 9 quarters since. The position peaked at $8.45K in Q1 2026. 100 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.
- BFC Planning held 5,000 shares of Coherus Oncology worth $6.05K as of Q3 2026.
- BFC Planning left its Coherus Oncology share count unchanged in Q3 2026.
- Coherus Oncology made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2597 holding.
- BFC Planning first reported a position in Coherus Oncology in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Coherus Oncology position peaked at $8.45K in Q1 2026.
- 100 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.